Pfizer Inc.
PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbreā¦ read more
Healthcare
Drug ManufacturersāGeneral
53 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$25.89
Price+1.19%
$0.30
1Y
Price
Market Cap
$147.203b
Large
Price/Earnings 3y Avg5y Avg
15.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+33.9%
EBITDA Margin+21.3%
Net Profit Margin+24.0%
Free Cash Flow Margin+33.9%
EBITDA Margin+21.3%
Net Profit Margin+24.0%
Free Cash Flow MarginRevenue
$62.785b
-1.3%
1y CAGR-11.7%
3y CAGR-2.9%
5y CAGREarnings
$9.821b
+22.5%
1y CAGR+68.4%
3y CAGR+61.7%
5y CAGREPS
$1.72
+22.0%
1y CAGR+69.9%
3y CAGR+62.7%
5y CAGRBook Value
$93.096b
$208.731b
Assets$115.635b
Liabilities$61.712b
DebtDebt to Assets
29.6%
2.9x
Debt to EBITDAFree Cash Flow
$10.376b
+5.5%
1y CAGR+9.7%
3y CAGR+4.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company